nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP1A2—chronic obstructive pulmonary disease	0.484	1	CbGaD
Rilpivirine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0604	0.162	CbGbCtD
Rilpivirine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0604	0.162	CbGbCtD
Rilpivirine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0474	0.127	CbGbCtD
Rilpivirine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0385	0.103	CbGbCtD
Rilpivirine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.026	0.0699	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0254	0.0681	CbGbCtD
Rilpivirine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0248	0.0667	CbGbCtD
Rilpivirine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0221	0.0594	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0217	0.0582	CbGbCtD
Rilpivirine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0205	0.0549	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.013	0.0349	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0123	0.0329	CbGbCtD
Rilpivirine—Buffalo hump—Prednisone—chronic obstructive pulmonary disease	0.00251	0.0242	CcSEcCtD
Rilpivirine—Adrenal insufficiency—Prednisone—chronic obstructive pulmonary disease	0.00241	0.0232	CcSEcCtD
Rilpivirine—Lipohypertrophy—Prednisone—chronic obstructive pulmonary disease	0.00231	0.0223	CcSEcCtD
Rilpivirine—Pazopanib—CYP1A2—chronic obstructive pulmonary disease	0.00169	1	CrCbGaD
Rilpivirine—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.00159	0.0154	CcSEcCtD
Rilpivirine—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.0154	CcSEcCtD
Rilpivirine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.0136	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.0129	CcSEcCtD
Rilpivirine—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.00132	0.0127	CcSEcCtD
Rilpivirine—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.0127	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—chronic obstructive pulmonary disease	0.00125	0.0121	CcSEcCtD
Rilpivirine—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.012	CcSEcCtD
Rilpivirine—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.011	CcSEcCtD
Rilpivirine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.0107	CcSEcCtD
Rilpivirine—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.0106	CcSEcCtD
Rilpivirine—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0104	CcSEcCtD
Rilpivirine—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0104	CcSEcCtD
Rilpivirine—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00105	0.0102	CcSEcCtD
Rilpivirine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000937	0.00903	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.009	CcSEcCtD
Rilpivirine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000895	0.00863	CcSEcCtD
Rilpivirine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000884	0.00852	CcSEcCtD
Rilpivirine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000875	0.00844	CcSEcCtD
Rilpivirine—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000873	0.00842	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000821	0.00791	CcSEcCtD
Rilpivirine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000815	0.00786	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000804	0.00775	CcSEcCtD
Rilpivirine—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000788	0.00759	CcSEcCtD
Rilpivirine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000783	0.00755	CcSEcCtD
Rilpivirine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000782	0.00754	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000778	0.0075	CcSEcCtD
Rilpivirine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000777	0.00749	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000737	0.0071	CcSEcCtD
Rilpivirine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00072	0.00695	CcSEcCtD
Rilpivirine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00687	CcSEcCtD
Rilpivirine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000699	0.00674	CcSEcCtD
Rilpivirine—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000694	0.00669	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000664	0.0064	CcSEcCtD
Rilpivirine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000647	0.00623	CcSEcCtD
Rilpivirine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000636	0.00613	CcSEcCtD
Rilpivirine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000636	0.00613	CcSEcCtD
Rilpivirine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.00608	CcSEcCtD
Rilpivirine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000631	0.00608	CcSEcCtD
Rilpivirine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000625	0.00602	CcSEcCtD
Rilpivirine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000623	0.006	CcSEcCtD
Rilpivirine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000618	0.00596	CcSEcCtD
Rilpivirine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000617	0.00594	CcSEcCtD
Rilpivirine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00579	CcSEcCtD
Rilpivirine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00576	CcSEcCtD
Rilpivirine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000596	0.00574	CcSEcCtD
Rilpivirine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00574	CcSEcCtD
Rilpivirine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00568	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000587	0.00566	CcSEcCtD
Rilpivirine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00561	CcSEcCtD
Rilpivirine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00561	CcSEcCtD
Rilpivirine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000578	0.00557	CcSEcCtD
Rilpivirine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000573	0.00552	CcSEcCtD
Rilpivirine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00549	CcSEcCtD
Rilpivirine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00548	CcSEcCtD
Rilpivirine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00547	CcSEcCtD
Rilpivirine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000565	0.00544	CcSEcCtD
Rilpivirine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000564	0.00544	CcSEcCtD
Rilpivirine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.00544	CcSEcCtD
Rilpivirine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000563	0.00543	CcSEcCtD
Rilpivirine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.0054	CcSEcCtD
Rilpivirine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00056	0.0054	CcSEcCtD
Rilpivirine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00536	CcSEcCtD
Rilpivirine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000552	0.00533	CcSEcCtD
Rilpivirine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.00531	CcSEcCtD
Rilpivirine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00529	CcSEcCtD
Rilpivirine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.00524	CcSEcCtD
Rilpivirine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000535	0.00516	CcSEcCtD
Rilpivirine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.00513	CcSEcCtD
Rilpivirine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.0051	CcSEcCtD
Rilpivirine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000522	0.00504	CcSEcCtD
Rilpivirine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00494	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00474	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000489	0.00472	CcSEcCtD
Rilpivirine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.00458	CcSEcCtD
Rilpivirine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000475	0.00458	CcSEcCtD
Rilpivirine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000475	0.00458	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00457	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00457	CcSEcCtD
Rilpivirine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.0045	CcSEcCtD
Rilpivirine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000467	0.0045	CcSEcCtD
Rilpivirine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00449	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00447	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000463	0.00447	CcSEcCtD
Rilpivirine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00438	CcSEcCtD
Rilpivirine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00438	CcSEcCtD
Rilpivirine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00433	CcSEcCtD
Rilpivirine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00432	CcSEcCtD
Rilpivirine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00432	CcSEcCtD
Rilpivirine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00432	CcSEcCtD
Rilpivirine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00429	CcSEcCtD
Rilpivirine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00428	CcSEcCtD
Rilpivirine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00428	CcSEcCtD
Rilpivirine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00425	CcSEcCtD
Rilpivirine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00424	CcSEcCtD
Rilpivirine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00419	CcSEcCtD
Rilpivirine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00414	CcSEcCtD
Rilpivirine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00408	CcSEcCtD
Rilpivirine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00404	CcSEcCtD
Rilpivirine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00399	CcSEcCtD
Rilpivirine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00399	CcSEcCtD
Rilpivirine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000411	0.00396	CcSEcCtD
Rilpivirine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00392	CcSEcCtD
Rilpivirine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00392	CcSEcCtD
Rilpivirine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00391	CcSEcCtD
Rilpivirine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00384	CcSEcCtD
Rilpivirine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000397	0.00383	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00381	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00381	CcSEcCtD
Rilpivirine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.0038	CcSEcCtD
Rilpivirine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000394	0.0038	CcSEcCtD
Rilpivirine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00377	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00373	CcSEcCtD
Rilpivirine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00372	CcSEcCtD
Rilpivirine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.0037	CcSEcCtD
Rilpivirine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000382	0.00368	CcSEcCtD
Rilpivirine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00365	CcSEcCtD
Rilpivirine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00365	CcSEcCtD
Rilpivirine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.00363	CcSEcCtD
Rilpivirine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00362	CcSEcCtD
Rilpivirine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000375	0.00361	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00361	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00361	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00359	CcSEcCtD
Rilpivirine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00359	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00353	CcSEcCtD
Rilpivirine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00349	CcSEcCtD
Rilpivirine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00349	CcSEcCtD
Rilpivirine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00036	0.00347	CcSEcCtD
Rilpivirine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00344	CcSEcCtD
Rilpivirine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00344	CcSEcCtD
Rilpivirine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00344	CcSEcCtD
Rilpivirine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00342	CcSEcCtD
Rilpivirine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00341	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.0034	CcSEcCtD
Rilpivirine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00329	CcSEcCtD
Rilpivirine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00325	CcSEcCtD
Rilpivirine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00316	CcSEcCtD
Rilpivirine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00316	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000323	0.00311	CcSEcCtD
Rilpivirine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000321	0.0031	CcSEcCtD
Rilpivirine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00302	CcSEcCtD
Rilpivirine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00302	CcSEcCtD
Rilpivirine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00299	CcSEcCtD
Rilpivirine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00295	CcSEcCtD
Rilpivirine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00292	CcSEcCtD
Rilpivirine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00292	CcSEcCtD
Rilpivirine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00286	CcSEcCtD
Rilpivirine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00285	CcSEcCtD
Rilpivirine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.0028	CcSEcCtD
Rilpivirine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000291	0.0028	CcSEcCtD
Rilpivirine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00278	CcSEcCtD
Rilpivirine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00278	CcSEcCtD
Rilpivirine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00278	CcSEcCtD
Rilpivirine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00278	CcSEcCtD
Rilpivirine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00276	CcSEcCtD
Rilpivirine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00276	CcSEcCtD
Rilpivirine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00275	CcSEcCtD
Rilpivirine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000285	0.00275	CcSEcCtD
Rilpivirine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00272	CcSEcCtD
Rilpivirine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00272	CcSEcCtD
Rilpivirine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00271	CcSEcCtD
Rilpivirine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00271	CcSEcCtD
Rilpivirine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00265	CcSEcCtD
Rilpivirine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00262	CcSEcCtD
Rilpivirine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00262	CcSEcCtD
Rilpivirine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00262	CcSEcCtD
Rilpivirine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00262	CcSEcCtD
Rilpivirine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00261	CcSEcCtD
Rilpivirine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00257	CcSEcCtD
Rilpivirine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00247	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00221	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00216	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00214	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00213	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000187	0.0018	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000186	0.0018	CcSEcCtD
Rilpivirine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00172	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000177	0.0017	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00169	CcSEcCtD
Rilpivirine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00158	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00157	CcSEcCtD
Rilpivirine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000157	0.00408	CbGpPWpGaD
Rilpivirine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00151	CcSEcCtD
Rilpivirine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00151	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.0015	CcSEcCtD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00404	CbGpPWpGaD
Rilpivirine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.00403	CbGpPWpGaD
Rilpivirine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000155	0.0015	CcSEcCtD
Rilpivirine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.0015	CcSEcCtD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00399	CbGpPWpGaD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00393	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000151	0.00392	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000149	0.00386	CbGpPWpGaD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00383	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000147	0.00382	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00142	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00142	CcSEcCtD
Rilpivirine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00378	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00378	CbGpPWpGaD
Rilpivirine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00137	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000136	0.00352	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000134	0.00349	CbGpPWpGaD
Rilpivirine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00124	CcSEcCtD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00335	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000127	0.0033	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00323	CbGpPWpGaD
Rilpivirine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00119	CcSEcCtD
Rilpivirine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000122	0.00318	CbGpPWpGaD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00311	CbGpPWpGaD
Rilpivirine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00115	CcSEcCtD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000115	0.00299	CbGpPWpGaD
Rilpivirine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000114	0.0011	CcSEcCtD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000114	0.00296	CbGpPWpGaD
Rilpivirine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00296	CbGpPWpGaD
Rilpivirine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00109	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00109	CcSEcCtD
Rilpivirine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00109	CcSEcCtD
Rilpivirine—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000112	0.00291	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.0029	CbGpPWpGaD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00286	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000109	0.00283	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Rilpivirine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00279	CbGpPWpGaD
Rilpivirine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00103	CcSEcCtD
Rilpivirine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00275	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000105	0.00273	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000105	0.00272	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000104	0.0027	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00261	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.88e-05	0.00256	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.44e-05	0.00245	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.23e-05	0.0024	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	9.22e-05	0.00239	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.11e-05	0.00237	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.04e-05	0.00235	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.81e-05	0.00229	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	8.76e-05	0.00227	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.75e-05	0.00227	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.74e-05	0.00227	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.69e-05	0.00226	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.63e-05	0.00224	CbGpPWpGaD
Rilpivirine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.58e-05	0.00223	CbGpPWpGaD
Rilpivirine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.3e-05	0.00215	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—CTGF—chronic obstructive pulmonary disease	8.21e-05	0.00213	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.16e-05	0.00212	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8e-05	0.00208	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.96e-05	0.00207	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.86e-05	0.00204	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	7.77e-05	0.00202	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	7.65e-05	0.00198	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	7.54e-05	0.00196	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.49e-05	0.00194	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.43e-05	0.00193	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.37e-05	0.00191	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.35e-05	0.00191	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.3e-05	0.00189	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	7.23e-05	0.00188	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.2e-05	0.00187	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.00183	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	6.98e-05	0.00181	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	6.87e-05	0.00178	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.81e-05	0.00177	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.75e-05	0.00175	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.72e-05	0.00174	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00174	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.71e-05	0.00174	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.62e-05	0.00172	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.61e-05	0.00172	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.61e-05	0.00172	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.52e-05	0.00169	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.36e-05	0.00165	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.27e-05	0.00163	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.2e-05	0.00161	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.13e-05	0.00159	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.95e-05	0.00154	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.76e-05	0.0015	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.59e-05	0.00145	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.51e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.44e-05	0.00141	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.44e-05	0.00141	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.37e-05	0.00139	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.35e-05	0.00139	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.11e-05	0.00133	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.07e-05	0.00132	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.04e-05	0.00131	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.04e-05	0.00131	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5e-05	0.0013	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.99e-05	0.0013	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.95e-05	0.00128	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.86e-05	0.00126	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.83e-05	0.00125	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.8e-05	0.00125	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.78e-05	0.00124	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.74e-05	0.00123	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.73e-05	0.00123	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.73e-05	0.00123	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.62e-05	0.0012	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.62e-05	0.0012	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.57e-05	0.00119	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.53e-05	0.00118	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.53e-05	0.00118	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.51e-05	0.00117	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.5e-05	0.00117	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.36e-05	0.00113	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.32e-05	0.00112	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.32e-05	0.00112	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.3e-05	0.00112	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.24e-05	0.0011	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.18e-05	0.00108	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.09e-05	0.00106	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.00103	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.95e-05	0.00102	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.95e-05	0.00102	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.92e-05	0.00102	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.9e-05	0.00101	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.89e-05	0.00101	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.87e-05	0.001	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.86e-05	0.001	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.000979	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.76e-05	0.000975	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.74e-05	0.000972	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.74e-05	0.000971	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.69e-05	0.000958	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.64e-05	0.000945	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.6e-05	0.000934	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.59e-05	0.000931	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.56e-05	0.000924	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000911	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.46e-05	0.000898	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.000879	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.32e-05	0.000861	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.3e-05	0.000855	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.000852	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.27e-05	0.000849	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.06e-05	0.000795	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.05e-05	0.000791	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.01e-05	0.000782	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.01e-05	0.00078	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.00075	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.85e-05	0.00074	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.76e-05	0.000715	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.00071	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.7e-05	0.000701	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.65e-05	0.000689	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.62e-05	0.000681	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.56e-05	0.000665	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.54e-05	0.000659	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.000653	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000649	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.49e-05	0.000646	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.46e-05	0.000638	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.44e-05	0.000635	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000631	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.43e-05	0.00063	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.000621	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000619	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.32e-05	0.000603	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.32e-05	0.000603	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.32e-05	0.000601	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000587	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000575	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.000572	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000559	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000557	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.04e-05	0.00053	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.02e-05	0.000524	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000518	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000504	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.94e-05	0.000503	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.85e-05	0.000481	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.000479	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000477	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.000472	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.000471	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000468	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000467	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.000462	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.73e-05	0.000449	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.7e-05	0.000442	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000439	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.68e-05	0.000436	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000422	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000421	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000416	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.000406	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.55e-05	0.000402	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.54e-05	0.0004	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.53e-05	0.000396	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.5e-05	0.000389	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.5e-05	0.000388	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000385	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000373	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.39e-05	0.000361	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000353	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	0.000349	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000345	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000341	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000325	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	0.000324	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000319	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000319	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000311	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000302	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.15e-05	0.000298	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000293	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000286	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000283	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	0.000282	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000275	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000272	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.00027	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000262	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.77e-06	0.000254	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.64e-06	0.00025	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.56e-06	0.000248	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.43e-06	0.000245	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.3e-06	0.000241	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.21e-06	0.000239	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.08e-06	0.000236	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	0.000225	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.46e-06	0.00022	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	0.000213	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.18e-06	0.000212	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.09e-06	0.00021	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.02e-06	0.000208	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.39e-06	0.000192	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.38e-06	0.000192	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.35e-06	0.000191	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.25e-06	0.000188	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.07e-06	0.000183	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.8e-06	0.000176	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.75e-06	0.000175	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.4e-06	0.000166	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.67e-06	0.000147	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.59e-06	0.000145	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.58e-06	0.000145	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	0.000141	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.34e-06	0.000139	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	0.000135	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.21e-06	0.000135	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.94e-06	0.000128	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.35e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-06	0.000108	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.36e-06	8.72e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.21e-06	8.34e-05	CbGpPWpGaD
